This is a discussion on Drug Class Review for Thiazolidinediones within the Comparative Effectiveness Updates forum, part of the Industry News and Updates category; The final report of the Drug Class Review for Thiazolidinediones (TZDs) has been posted by the Drug Effectiveness and Review ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
The final report of the Drug Class Review for Thiazolidinediones (TZDs) has been posted by the Drug Effectiveness and Review Project (DERP) at the Oregon Health and Science University. This is an updated review from the 2005 version. Key updates include comparative efficacy and safety between these products and the efficacy with other classes as well.
Link to the final report: Norris SL, Carson S. Drug class review: Thiazolidinediones. 2008. Drug Class Review of Thiazolidinediones |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Review Addresses Pharmacologic Treatments of Insomnia | industry_news | Other Clinical Pharmacy News | 0 | 08-19-2008 03:31 PM |
| New Update on Infective Endocarditis Prophylaxis: Now a Class IIa Recommendation | industry_news | Other Clinical Pharmacy News | 0 | 08-01-2008 10:28 PM |
| FDA delays review of Eli Lilly’s would-be blockbuster | industry_news | Biotechnology News | 0 | 06-24-2008 04:17 PM |
| Talecris' antibody drug gets priority review | industry_news | Biotechnology News | 0 | 05-09-2008 09:06 PM |
| FDA Issues Early Communication about an Ongoing Review of Vytorin | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |